Press release
Sciatica Clinical Trials | A Drug Pipeline Analysis Report 2024 | Sollis Therapeutics, Scilex Holding
United States, Nevada, Las Vegas, DelveInsight's 'Sciatica Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sciatica therapies in various stages of clinical development, major pharmaceutical companies are working to advance the pipeline space and future growth potential of the Sciatica pipeline domain.Download sample pages @ https://www.delveinsight.com/report-store/sciatica-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Key Takeaways from the Sciatica Pipeline Report
Over 5+ Sciatica pipeline therapies are in various stages of development, and their anticipated acceptance in the Sciatica market would significantly increase market revenue.
Leading Sciatica companies developing novel drug candidates to improve the Sciatica treatment landscape include Sollis Therapeutics, Scilex Holding, and others.
Promising Sciatica pipeline therapies in various stages of development include STX-015, SP-102, and others.
Sciatica Overview
Sciatica refers to pain that radiates along the path of the sciatic nerve, which branches from your lower back through your hips and buttocks and down each leg. It usually affects one side of the body. Sciatica is not a medical condition itself but rather a symptom of an underlying problem, such as a herniated disc pressing on the nerve roots that lead to the sciatic nerve.
Sciatica Causes:
The most common cause of sciatica is a herniated disc in the lumbar spine (lower back) that compresses or irritates the nerve roots. Other causes may include:
1. Degenerative disc disease: Wear and tear on the discs that cushion the vertebrae.
2. Spinal stenosis: Narrowing of the spinal canal, which can compress the nerves.
3. Spondylolisthesis: A condition where one vertebra slips forward over another.
4. Piriformis syndrome: Irritation or compression of the sciatic nerve by the piriformis muscle in the buttocks.
Sciatica Signs and Symptoms:
The hallmark symptom of sciatica is pain that radiates from the lower back or buttock down the back of one thigh and into the leg. The pain can vary widely, from a mild ache to a sharp, burning sensation or excruciating discomfort. Other common symptoms include:
1. Pain that worsens with sitting: Particularly if prolonged sitting increases pressure on the sciatic nerve.
2. Numbness or tingling: Along the path of the sciatic nerve, often extending into the toes.
3. Weakness: Difficulty moving the leg or foot, especially when trying to lift the heel off the ground or walk on toes.
Sciatica Diagnosis:
1. Medical History and Physical Examination: Your doctor will ask about your symptoms, conduct a physical exam to check your reflexes, muscle strength, and sensation in affected areas.
2. Imaging Tests:
- MRI (Magnetic Resonance Imaging): Provides detailed images of the spine and can show herniated discs, spinal stenosis, or other structural problems.
- CT (Computed Tomography) Scan: Sometimes used to get a more detailed view of the spine and nerve roots.
- X-rays: To rule out other causes of back pain, such as fractures or arthritis.
3. Electromyography (EMG) and Nerve Conduction Studies: May be performed to assess nerve function and determine if there is any nerve damage.
Sciatica Treatment Options:
Treatment for sciatica depends on the underlying cause and severity of symptoms. Options include:
1. Medications:
- Over-the-counter pain relievers: Such as ibuprofen or acetaminophen to reduce pain and inflammation.
- Muscle relaxants: To relieve muscle spasms.
- Prescription medications: Such as corticosteroids or stronger pain medications in severe cases.
2. Physical Therapy:
- Specific exercises and stretches to strengthen the muscles supporting the back, improve flexibility, and reduce pressure on the sciatic nerve.
3. Injection Therapy:
- Epidural steroid injections: To reduce inflammation and relieve pain by delivering steroids directly into the affected area of the spine.
- Trigger point injections: To alleviate pain caused by muscle spasms, particularly in piriformis syndrome.
4. Alternative Therapies:
- Chiropractic adjustments: Manipulation of the spine to improve alignment and reduce pressure on the sciatic nerve.
- Acupuncture: Fine needles inserted into specific points to alleviate pain and improve nerve function.
5. Surgery:
- Diskectomy or laminectomy: Surgical procedures to remove part of a herniated disk or bone spur pressing on the nerve root.
- Microdiscectomy: Minimally invasive surgery to remove a small portion of a herniated disk.
6. Self-care measures:
- Applying hot or cold packs: To alleviate pain and reduce inflammation.
- Maintaining good posture: Especially when sitting, to avoid putting pressure on the sciatic nerve.
- Avoiding prolonged sitting or standing: Alternating positions and taking breaks to reduce stress on the spine.
Sciatica Market Outlook:
Most cases of sciatica resolve with conservative treatments like medications, physical therapy, and self-care measures. Surgery is typically considered only when symptoms persist despite conservative treatment or if there is severe nerve compression requiring immediate intervention. Early diagnosis and appropriate management can help alleviate symptoms and prevent recurrence of sciatica.
Request for sample pages @ https://www.delveinsight.com/sample-request/sciatica-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Sciatica Pipeline Analysis: Drug Profile
STX-015: Sollis Therapeutics
STX-015 is an Alpha 2 adrenergic receptor agonist being developed by Sollis Therapeutics for the treatment of sciatica. Currently, it is in Phase III stage of clinical trial evaluation.
Discover more about the emerging Sciatica drugs @ https://www.delveinsight.com/sample-request/sciatica-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Sciatica Key Companies
Sollis Therapeutics
Scilex Holding
Sciatica Pipeline Therapies
STX-015
SP-102
Sciatica Pipeline Therapeutics Assessment
By development stage
By product type
By route of administration
By molecule type
By MOA type
Scope of the Sciatica Pipeline Report
Coverage: Global
Key Sciatica Companies: Sollis Therapeutics, Scilex Holding, and others
Key Sciatica Pipeline Therapies: STX-015, SP-102, and others
Find out more about the Sciatica treatment options in development @ https://www.delveinsight.com/sample-request/sciatica-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Contents
1. Introduction
2. Executive Summary
3. Overview
4. Pipeline Therapeutics
5. Late-Stage Products (Phase III)
6. Mid-Stage Products (Phase II)
7. Early Stage Products (Phase I/II)
8. Preclinical Stage Products
9. Discovery Stage Products
10. Therapeutic Assessment
11. Inactive Products
12. Collaborations Assessment- Licensing / Partnering / Funding
13. Unmet Needs
14. Market Drivers and Barriers
15. Appendix
16. About DelveInsight
Download a free sample report: https://www.delveinsight.com/sample-request/sciatica-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Trending Reports By DelveInsight:
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market
Contact Us:
Kritika Rehani
info@delveinsight.com
+14699457679
About DelveInsight:
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sciatica Clinical Trials | A Drug Pipeline Analysis Report 2024 | Sollis Therapeutics, Scilex Holding here
News-ID: 3596319 • Views: …
More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Sciatica
Sciatica Market Insights and Future Outlook
Sciatica Market Outlook 2024-2034: Expanding Therapies and Rising Patient Awareness
Introduction
Sciatica, a common condition characterized by radiating pain along the sciatic nerve pathway, affects millions of individuals globally. The condition is usually caused by a herniated disc, spinal stenosis, or degenerative spine disorders, and it leads to chronic discomfort, reduced mobility, and lowered quality of life. As populations age and sedentary lifestyles increase, the prevalence of sciatica is rising steadily.
The growing…
Sciatica Obesity Trends Driving Demand For Pain Relief Solutions: A Key Catalyst …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sciatica Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
There has been robust growth in the market size for sciatica treatment in the past few years. The market is set to expand from $4.57 billion in 2024 to $4.99 billion in 2025, reflecting a…
Rising Orthopedic Procedures Propel Growth in the Sciatica Market: Strengthening …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
What Is the Expected CAGR for the Sciatica Market Through 2025?
Lately, the market size for sciatica has demonstrated robust growth. It is predicted to escalate from $6.93 billion in 2024 to $7.35 billion in 2025, with a compound annual growth rate (CAGR) of 6.0%. The remarkable expansion in…
Sciatica Obesity Trends Driving Demand For Pain Relief Solutions Driver: Leading …
What combination of drivers is leading to accelerated growth in the sciatica treatment market?
The rise in obesity is predicted to contribute significantly to the expansion of the sciatica treatment market. Obesity is a health condition marked by an excessive accumulation of body fat, effectively increasing the likelihood of heart disease, diabetes, and hypertension. This surge in obesity is mainly due to the easy accessibility to high-calorie processed foods coupled with…
Transforming the Sciatica Treatment Market in 2025: Sciatica Obesity Trends Driv …
What Is the Expected Size and Growth Rate of the Sciatica Treatment Market?
The market size for sciatica treatment has seen robust expansion in recent times. The market, standing at $4.57 billion in 2024, is predicted to escalate to $4.99 billion in 2025, showcasing a compound annual growth rate (CAGR) of 9.3%. This progress throughout the historic period is due to factors such as the surge in demand for non-surgical sciatica…
Sciatica Market Report 2032, DelveInsight | Sciatica Therapies & Companies, Clin …
As per DelveInsight, the Sciatica Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of Sciatica in the 7MM.
DelveInsight's "Sciatica Market Insights, Epidemiology, and Market Forecast 2032 [https://www.delveinsight.com/report-store/sciatica-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Sciatica market size, share, trends, and growth opportunities in the seven…